Grant ID

14T-004

Illness

Schizophrenia

Primary Drug/Intervention

Intravenous immunoglobulin or plasma exchange

Primary Dosage

2g/kg

Secondary Drug Intervention

N/A

Secondary Dosage

N/A

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Completed

Investigator

Coles

Sample Size

15

Duration of Study Period for Each Subject

60 days

Outcome Measurements

N/A

Results

N/A

Publication

N/A

Link

N/A

PI Name

Alasdair J Coles

Degree

N/A

Center

Department of Clinical Neurosciences

Institution

Cambridge University

Address

City or Town

N/A

State or Province

N/A

Zip or Postal Code

N/A

Country

United Kingdom

Email Address

ajc1020@medschl.cam.ac.uk